Libros importados con hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Pay-For-Delay Deals: Limiting Competition and Costing Consumers (in English)
Type
Physical Book
Language
Inglés
Pages
134
Format
Paperback
Dimensions
28.0 x 21.6 x 0.7 cm
Weight
0.33 kg.
ISBN13
9781514385494

Pay-For-Delay Deals: Limiting Competition and Costing Consumers (in English)

Competition P Subcommittee on Antitrust (Author) · Createspace Independent Publishing Platform · Paperback

Pay-For-Delay Deals: Limiting Competition and Costing Consumers (in English) - Subcommittee on Antitrust, Competition P

Physical Book

$ 15.16

$ 18.95

You save: $ 3.79

20% discount
  • Condition: New
It will be shipped from our warehouse between Monday, June 24 and Tuesday, June 25.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Pay-For-Delay Deals: Limiting Competition and Costing Consumers (in English)"

In 2012, analysts estimate that Americans spent $325 billion on prescription drugs and they predict that drug sales will rise by more than four percent in the year 2014. Generic drugs, which can cost as much as 90 percent lower than brand-name drugs, help rein in the costs. A brand-name drug that costs $300 per month might be sold as a generic for as little as $30 per month, but for several years, pay-for-delay deals have robbed consumers of cost-saving generic drugs. At the very core, these deals involve collusion between brand and generic competitors to keep generic competition off the market. A brand-name drug company pays their generic competitor cash or another form of payment. In exchange, the generic delays its entry into the marketplace. The brand company wins because it gets to maintain its monopoly, and the generic company wins because they get paid more than they would have if they came to market. But American consumers and American taxpayers lose out on lower-cost generic drugs to the tune of billions of dollars each year, $3.5 billion according to the Federal Trade Commission.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews